©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Oct 28, 2025; 17(10): 108804
Published online Oct 28, 2025. doi: 10.4329/wjr.v17.i10.108804
Published online Oct 28, 2025. doi: 10.4329/wjr.v17.i10.108804
Hepatocellular carcinoma treatment response: Imaging findings and criteria
Francesco Agnello, Adele Taibbi, Massimo Galia, Alessia Orlando, Cesare Gagliardo, Tommaso Vincenzo Bartolotta, Department of Radiology, University Hospital "Paolo Giaccone", Palermo 90127, Italy
Author contributions: Agnello F, Galia M and Bartolotta TV were guarantors of the integrity of the study; Agnello F, Galia M, Gagliardo C and Orlando A contributed to the manuscript drafting and revision; Bartolotta V and Galia M contributed to manuscript editing. All authors contributed to literature search and approved the final version of the paper.
Conflict-of-interest statement: Authors have no conflict of interest.
Corresponding author: Tommaso Vincenzo Bartolotta, MD, PhD, Full Professor, Department of Radiology, University Hospital "Paolo Giaccone", Via del Vespro 129, Palermo 90127, Italy. tommasovincenzo.bartolotta@unipa.it
Received: April 24, 2025
Revised: June 16, 2025
Accepted: September 17, 2025
Published online: October 28, 2025
Processing time: 187 Days and 19.9 Hours
Revised: June 16, 2025
Accepted: September 17, 2025
Published online: October 28, 2025
Processing time: 187 Days and 19.9 Hours
Core Tip
Core Tip: Computed tomography and magnetic resonance imaging play a crucial role in the evaluation of hepatocellular carcinoma (HCC) treatment response. Contrast en
